Senti Biosciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.3% | -14.5% | -14.9% | -33.6% | +69.5% | -15.4% | -17.2% | -23.1% | -2.8% | -25.3% | -13.4% | |
| – | -9.9% | -21.8% | -20.3% | -60.8% | +239.2% | -23.3% | -28.1% | -44.2% | +28.2% | -36.5% | -12.1% | |
| – | -8.9% | -34.0% | -33.1% | -33.9% | +360.7% | -30.0% | -36.2% | -43.3% | +34.1% | -45.6% | -27.7% | |
| – | -8.9% | -34.0% | -33.1% | -33.9% | +360.7% | -30.0% | -36.2% | -43.3% | +34.1% | -45.6% | -27.7% | |
| – | -4.9% | +1.2% | +4.1% | -93.6% | +52.1% | +22.9% | +66.5% | -52.8% | -8.5% | -52.0% | -27.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.7% | -12.3% | -7.2% | -2.4% | +73.0% | -37.8% | -2.3% | +1.5% | +2.4% | -21.8% | +2.3% | |
| – | +25.3% | -24.2% | -5.6% | 0.0% | +45.0% | -18.4% | -6.9% | +20.4% | +16.2% | +2.1% | +10.5% | |
| – | +53.9% | +3.6% | +3.6% | +3.6% | +3.5% | +1.3% | +3.5% | +3.5% | +3.4% | +10.5% | +27.1% | |
| – | -37.2% | +29.9% | -27.3% | -32.9% | +83.4% | +7.2% | -34.6% | +73.6% | +66.2% | -64.3% | +113.7% | |
| – | -19.3% | -16.2% | -21.3% | -63.8% | +60.4% | +47.6% | -34.9% | -67.1% | -31.2% | -54.1% | -232.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | +1.5% | +0.0% | +0.1% | +0.4% | +117.9% | +160.5% | +0.6% | -14.3% | +37.8% | +0.6% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.